Cargando…
Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports
BACKGROUND: Myelodysplastic syndromes are heterogeneous disorders. Patients with myelodysplastic syndrome disease often have ineffective hematopoiesis, cytopenias, blood cell dysplasia in one or more cell types, and are at high risk for developing acute myeloid leukemia. In myelodysplastic syndrome,...
Autores principales: | Duarte, Fernando Barroso, Lemes, Romélia Pinheiro Gonçalves, dos Santos, Talyta Ellen de Jesus, Barbosa, Maritza Cavalcante, de Vasconcelos, João Paulo Leitão, Rocha-Filho, Francisco Dário, Zalcberg, Ilana, Coutinho, Diego, Figueiredo, Monalisa Feliciano, Carlos, Luciana Barros, de Vasconcelos, Paulo Roberto Leitão |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438849/ https://www.ncbi.nlm.nih.gov/pubmed/28527473 http://dx.doi.org/10.1186/s13256-017-1301-8 |
Ejemplares similares
-
Tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome
por: Duarte, Fernando Barroso, et al.
Publicado: (2014) -
Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil
por: Moura, Anna Thawanny Gadelha, et al.
Publicado: (2019) -
Myelodysplastic syndrome versus idiopathic cytopenia of undetermined
significance: the role of morphology in distinguishing between these
entities
por: dos Santos, Talyta Ellen de Jesus, et al.
Publicado: (2013) -
Idiopathic cytopenia of undetermined significance and systemic lupus
erythematosus
por: Gonçalves, Romelia Pinheiro, et al.
Publicado: (2013) -
Comet assay in myelodysplastic syndromes
por: Teixeira Neto, Paulo Florentino, et al.
Publicado: (2012)